 |
 |
|
|
Home | About Us | Projects | People | Links | Contact Us | |
Welcome:
The Coulter Translational Research Partnership is a $20M program that funds cutting edge biomedical technologies with the purpose of improving clinical practice. The program is also dedicated to training serial innovators in translational research and commercialization. Support and financing is based on technical merit, clinical impact, strength of team, intellectual property, and likelihood for adoption. Significant funding for the Coulter Translational Research Partnership was provided by the Wallace H. Coulter Foundation. |
News & Events:
November 2012 Rivanna Medical featured in Daily Progress October 2012 HemoShear closes $4M funding round September 2012 HemoShear closes $1 million dollar debt financing July 2012 HemoSonics received $100,000 in funding from CIT July 2012 HemoShear featured in Daily Progress news December 2011 The Center for Innovative Technology (CIT) recently announced its grant awards for Fall 2011. Several Coulter funded start-up companies were awarded funds through the Commonwealth Commercialization Research Fund. More... October 2011 FDA To Companion DX Developers: Pre-Trial Assay Validation is Key (pdf) September 26 The UVA-Coulter Partnership co-hosted a conference with the FDA. The conference was focused on translational research and the FDA regulatory process and was titled Medical Device Technology Innovation Partnerships. May 3, 2011 The Wallace H. Coulter Foundation Translational Research Partnership Award Creates a $20 Million U.Va. Endowment for Translational Research in Biomedical Innovation. Read more... December 3, 2010 Twelve UVa-related biotechnology firms were awarded over $2.7 million in grants under the new Qualified Therapeutic Discovery Project Program. To read more, please visit UVa Today. Coulter ROPe Funds Coulter Partnership announces new and innovate source of funds to support faculty translational research. Coulter ROPE Funds (pdf) |
